Confluent CFO sale at $23.51–$24 under Rule 10b5-1

Rhea-AI Filing Summary

Confluent (CFLT) Form 4: The Chief Financial Officer sold 6,000 shares of Class A common stock on 10/29/2025 pursuant to a Rule 10b5-1 trading plan dated September 12, 2024. The filing notes sale prices ranged from $23.51 to $24.00, with a line-item price shown at $23.76 for the reported transaction. Following the sale, the reporting person beneficially owns 625,596 shares, held directly.

Insider Trade Summary

Net Seller: 6,000 shares ($142,560)

Net Sell 1 txn

Insider Sivaram Rohan

Role CHIEF FINANCIAL OFFICER

Sold 6,000 shs ($143K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	6,000	$23.76	$143K

Holdings After Transaction: Class A Common Stock — 625,596 shares (Direct)

Footnotes (1)

1. Shares sold pursuant to a 10b5-1 trading plan dated September 12, 2024. The shares were sold at prices ranging from $23.51 to $24.00. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sivaram Rohan

(Last) (First) (Middle)

C/O CONFLUENT, INC.

899 W. EVELYN AVENUE

(Street)

MOUNTAIN VIEW CA 94041

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Confluent, Inc. [ CFLT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF FINANCIAL OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
10/29/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	10/29/2025		S		6,000(1)	D	$23.76(2)	625,596	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares sold pursuant to a 10b5-1 trading plan dated September 12, 2024.

2. The shares were sold at prices ranging from $23.51 to $24.00. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

	/s/ Weilyn Wood, Attorney-in-Fact	10/31/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Confluent (CFLT)’s insider report on this Form 4?

The Chief Financial Officer sold 6,000 shares of Class A common stock on 10/29/2025.

At what prices were the CFLT shares sold?

The filing states a price range of $23.51 to $24.00, with a reported transaction price line at $23.76.

Was the sale under a Rule 10b5-1 plan?

Yes. The shares were sold pursuant to a Rule 10b5-1 trading plan dated September 12, 2024.

How many CFLT shares does the officer own after the sale?

The reporting person beneficially owns 625,596 shares directly after the transaction.

Which security was involved in the transaction?

The transaction involved Class A common stock of Confluent, Inc.

Who filed the form and in what capacity?

It was filed by one reporting person who is an Officer (Chief Financial Officer).